BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2004
View Archived Issues
OATs mediate muscular side effects of HMG-CoA reductase inhibitors
Read More
Novel NNRTIs for HIV
Read More
ProtoKinetix obtains option to license mammastatin-based products
Read More
CellTech and Biogen Idec enter CD40L collaboration for autoimmune disease
Read More
GeneProt amends collaboration with Novartis
Read More
Strong antiretroviral response found with fosamprenavir in naive HIV-infected patients
Read More
Improved efficacy of antianginal drugs after coadministration with ranolazine
Read More
Preliminary results of adalimumab in the treatment of chronic plaque psoriasis
Read More
Connetics to acquire Soriatane
Read More
Eisai licenses rufinamide from Novartis
Read More
Transgene updates status of phase II trials of MVA-Muc1-IL2
Read More
NexMed enters agreement to develop topical pain relief gel
Read More
Nabi signs distribution agreement with Kamada for Nabi-HB
Read More
Matrixx reaffirms safety of Zicam intranasal gel
Read More
Genome Therapeutics completes merger with Genesoft
Read More
Neurocrine Biosciences updates clinical programs
Read More
Clinical benefits of topical tacrolimus in the treatment of skin disorders
Read More
2003 reportedly an important year of transition at InterMune
Read More
PharmaMar refocuses business plan
Read More
Mechanistic basis for novel therapeutic strategies aimed at reducing BH4 levels in ischemic stroke
Read More
Yamanouchi presents new inhibitors of reverse Na+/Ca2+ exchange
Read More
Novel HIV reverse transcriptase inhibitors claimed by BMS team
Read More
Euroceltique patent covers new inhibitors of VR1 and/or mGluR receptors
Read More
German scientists present proapoptotic IAP modulators for use in cancer therapy
Read More
Two series of antibacterial macrolides presented by Enanta researchers
Read More
AstraZeneca describes three series of cathepsin S inhibitors
Read More
New glucokinase activators in early development at Novo Nordisk
Read More
Potential utility of Tamiflu for avian flu
Read More
New study evaluates GTI-2040 plus gemcitabine for solid tumors
Read More
Launch of Climara Pro
Read More